Stocks Comparison
Edwards Lifesciences vs Smith & Nephew: revenue, profit, margins and growth compared
Edwards Lifesciences brought in $6.1B of revenue in fiscal 2025, Smith & Nephew $6.2B in fiscal 2025. Revenue changed by +11.5% at Edwards Lifesciences and +6.1% at Smith & Nephew on the year before, so Edwards Lifesciences grew faster. Edwards Lifesciences kept 17.7% of its revenue as net profit, Smith & Nephew 10.1%.
Side by side, latest fiscal year
| EW | SNN | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $6.1B | $6.2B |
| Revenue growth | +11.5% | +6.1% |
| Net income | $1.1B | $625M |
| Net margin | 17.7% | 10.1% |
| Free cash flow | $1.3B | n/a |
| Free cash flow margin | 22.0% | n/a |
| Earnings per share (diluted) | $1.83 | $0.72 |
| Cash | $2.9B | $557M |
| Debt | $598.3M | $3.1B |
| Price to earnings | 47.5 | n/a |
| Market value | $50B | $11.5B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #57 of 742 · Health care | #56 of 742 · Health care |
Over the years
Questions about Edwards Lifesciences and Smith & Nephew
Which is bigger by revenue, Edwards Lifesciences or Smith & Nephew?
Smith & Nephew is bigger by revenue: $6.2B in fiscal 2025, against $6.1B for Edwards Lifesciences in fiscal 2025.
Which keeps more of its revenue as profit, Edwards Lifesciences or Smith & Nephew?
Edwards Lifesciences had a net margin of 17.7% in fiscal 2025; Smith & Nephew had 10.1% in fiscal 2025.
Which grew revenue faster, Edwards Lifesciences or Smith & Nephew?
In their latest fiscal years revenue changed by +11.5% at Edwards Lifesciences and +6.1% at Smith & Nephew.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.